39 news items
Page 2 of 2
hybikaj7k3d8iup8qrendy3e8y5
ABBV
BMY
17 May 24
, with a price target of $200.
Cantor expects that Bristol-Myers
s3kwboxqyqalcpsc8ar7gz8k faljbvmmd7eqds
ABBV
17 May 24
Insights from analysts' 12-month price targets are revealed, presenting an average target of $190.4, a high estimate
7h9wxxd7ttq6jvsvje67beumhysr0 efni
ABBV
17 May 24
*The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)-II recommendations were
i91jprny
ABBV
17 May 24
Cantor Fitzgerald analyst Louise Chen initiates coverage on AbbVie (NYSE:ABBV) with a Overweight rating and announces Price Target of $200.
xn5io8ndouc1y6jozk2plbj8im1200ocwm5vke0xz32enpas9jpagf9il5j1
ABBV
14 May 24
, 2 industry analysts have shared their insights on this stock, proposing an average target price of $183.5.
Consistent
pg2u6c81y92coxx94j ci
ABBV
13 May 24
-generation versions known as neuroplastogens target mechanisms that have shown potential to provide significant clinical benefits and are designed
k99nxi6fw
ABBV
ATNM
AZN
8 May 24
totaling $750 million. This acquisition aims to bolster Novartis's pipeline with Mariana's advanced cancer-targeting radioligand therapies. Additionally
nwh0dt92
ABBV
29 Apr 24
Analysts have set 12-month price targets for AbbVie, revealing an average target of $189.75, a high estimate of $195.00, and a low
5p7cjlw2zpur6emq4bpav4rzzbpwh0rcpjw4xe8i4vv6mv
ABBV
29 Apr 24
BMO Capital analyst Evan David Seigerman maintains AbbVie (NYSE:ABBV) with a Outperform and lowers the price target from $195 to $180.
kzkgzlyaab5av821ou4o23aaqotruay5oyhlmdq5y e2jsgvznio0c
ABBV
23 Apr 24
spotted trades, 3 are puts, for a total amount of $162,900 and 12, calls, for a total amount of $749,820.
What's The Price Target?
Taking
ma2vxnh0 nfhk2sj
ABBV
ATNM
AZN
22 Apr 24
robust through 2024, particularly targeting mid-stage companies with deal values ranging between $1-3 billion. The focus is likely to center on critical
4n53z gqmc42g0h
ABBV
ATNM
AZN
19 Apr 24
. (NYSE:ATNM), with its groundbreaking advancements in targeted radiotherapies, underscores the burgeoning appeal
9np5crc22uhtcv04hu539ed3nt44kwkh2mppn2r5alebuj1ng6hwsa27
ABBV
18 Apr 24
of promising new pathways and targets, ultimately helping more people living with rheumatic diseases reach their treatment goals
0z9mraf7s5pkdkb6e0rx8mauikjpss09wn0ltoz3ujqut80ldygcu00jxbsd
ABBV
AVTX
LLY
16 Apr 24
, setting a $35 price target based on the belief that AVTX-009 could stand out in the competitive HS market
s6vd90z4rupenkx5ca3as5p002
ABBV
15 Apr 24
issued ratings for this stock, with a consensus target price of $192.5.
Maintaining their stance, an analyst from Guggenheim continues
zzzik6 mlum5h8i08cugvwtw7ebm82s9b7bpzqsezjhy
ABBV
12 Apr 24
into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $70.0 to $180.0 for AbbVie over
dum6wqijvsx1 c1cxe74tjsn3y2murua5oa4o8u4xz25qhqtrrfwoki0gt
ABBV
LENZ
10 Apr 24
near-vision loss) treatment.
Citigroup has initiated coverage on LENZ Therapeutics with a Buy rating and a price target of $34
n3udj8ykj1p1f1y7mpyi7x4kclua6v32thzc81ylkke39f35z
ABBV
5 Apr 24
into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $125.0 to $195.0 for AbbVie
4pxv5pkw0hqtnqel6mtbwgofdwyg2c6hnwxpkodn9 9ghga5yf3ibax9e20f
ABBV
4 Apr 24
spotted trades, 5 are puts, for a total amount of $176,561 and 5, calls, for a total amount of $617,570.
Projected Price Targets
Based